Eplerenone and Vitamin e drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Eplerenone (eplerenone) and Vitamin e (tocopherols and tocotrienols). Common drug interactions include death among females and cardiac failure acute among males.

The phase IV clinical study analyzes what interactions people have when they take Eplerenone and Vitamin e. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Eplerenone?

Eplerenone has active ingredients of eplerenone. It is often used in high blood pressure. eHealthMe is studying from 9,979 Eplerenone users. Check the latest studies of Eplerenone.

What is Vitamin e?

Vitamin e has active ingredients of tocopherols and tocotrienols. It is often used in vitamin supplementation. eHealthMe is studying from 42,279 Vitamin e users. Check the latest studies of Vitamin e.



On Jul, 28, 2026

21 people who take Eplerenone and Vitamin e together, and have interactions are studied.

Eplerenone and Vitamin e drug interactions.

What are the common drug interactions of Eplerenone and Vitamin E, by gender? *:

female:

  1. Death
  2. Peripheral swelling
  3. Arthropathy
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Constipation
  6. Depression
  7. Fatigue (feeling of tiredness)
  8. Hallucination (an experience involving the perception of something not present)
  9. Insomnia (sleeplessness)
  10. Pain

male:

  1. Cardiac failure acute
  2. Cardiac failure congestive
  3. Hypotension (abnormally low blood pressure)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Adverse drug reaction
  6. Blood potassium decreased
  7. Catheter site swelling
  8. Chronic kidney disease
  9. Depression
  10. Device dislocation

What are the common drug interactions of Eplerenone and Vitamin E, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Catheter site swelling
  3. Device dislocation

30-39:

n/a

40-49:

n/a

50-59:

  1. Cardiac failure acute
  2. Cardiac failure congestive
  3. Hepatomegaly (abnormal enlargement of the liver)
  4. Left ventricular failure (left ventricle fails to contract forcefully)
  5. Nephrolithiasis (calculi in the kidneys)
  6. Hypokalaemia (low potassium)
  7. Blood potassium decreased
  8. Transplant rejection (a transplant material is not worked)

60+:

  1. Adverse event
  2. Anaemia (lack of blood)
  3. Insomnia (sleeplessness)
  4. Palpitations (feelings or sensations that your heart is pounding or racing)
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  6. Peripheral swelling
  7. Poor quality sleep
  8. Rash erythematous (redness of the skin)
  9. Rash pruritic (redness with itching)
  10. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 14.29%
  2. Back Pain: 3 people, 14.29%
  3. Pain: 2 people, 9.52%
  4. Multiple Myeloma (cancer of the plasma cells): 2 people, 9.52%
  5. Insomnia (sleeplessness): 2 people, 9.52%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 9.52%
  7. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 9.52%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.52%
  9. Chest Pain: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Eplerenone and Vitamin e?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Eplerenone and Vitamin e:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Eplerenone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vitamin e:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Eplerenone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vitamin e and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on eplerenone and tocopherols and tocotrienols (the active ingredients of Eplerenone and Vitamin e, respectively), and Eplerenone and Vitamin e (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: